Showing 671-680 of 1742 results for "".
In-Hospital Blood Pressure Control After Acute Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/in-hospital-blood-pressure-control-after-acute-ischemic-stroke/31860/Blood pressure control plays an important role in stroke outcomes.Imaging Outcome Measures in Neuromuscular Diseases
https://practicalneurology.com/diseases-diagnoses/neuromuscular/imaging-outcome-measures-in-neuromuscular-diseases/35584/MRI is an important tool for assessing muscle and nerve changes in neuromuscular disease and is helpful to clinicians in monitoring therapeutic outcomes.Prognostic Factors in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/prognostic-factors-in-multiple-sclerosis/31874/Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time.Management of Poststroke Mobility and Spasticity
https://practicalneurology.com/diseases-diagnoses/stroke/management-of-poststroke-mobility-and-spasticity/32187/Mobility and spasticity management tailored appropriately to the individual’s needs and abilities, as well as early rehabilitation, result in reduced disability levels and optimized outcomes after stroke.Dementia Insights: Primary Prevention of Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-primary-prevention-of-dementia/31722/Evidence for modifiable lifestyle factors for dementia prevention is growing.I Object! Questions Facing Physicians' Rights to Dispute Sunshine Data
https://practicalneurology.com/columns/practice-management/i-object-questions-facing-physicians-rights-to-dispute-sunshine-data-deckwill-your-practic/30643/Will your practice be prepared when CMS posts Sunshine disclosures later this year?An Update on Antiplatelet Therapy for Secondary Stroke Prevention
https://practicalneurology.com/diseases-diagnoses/stroke/PN0809_03-php/30895/Recent data on stroke, insights from other specialties, and developments in the antiplatelet arena may influence management of stroke patients.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31497/Natalizumab (Tysabri) in Multiple Sclerosis Management: A Comprehensive OverviewNatalizumab, marketed as Tysabri, represents a significant advancement in the treatment of relapsing-remitting multiple sclerosis (RRMS). As the first α4-integrin antagonist within the selective adhesion molecule (SAM) i
Poststroke Telerehabilitation
https://practicalneurology.com/diseases-diagnoses/stroke/poststroke-telerehabilitation/31673/The role of telerehabilitation is evolving rapidly.Considerations for the Management of Optic Neuritis in the Inpatient Setting
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/considerations-for-the-management-of-optic-neuritis-in-the-inpatient-setting/31976/Optic neuritis is not only a potential presenting symptom of multiple sclerosis but of other demyelinating and autoimmune diseases.